Allergen crosses a susceptible interface
Pollen, food, venom, medicines, mites, animals, molds, occupational material, and other antigens enter distinct barrier tissues.
IMMUNE / 10
Allergy develops when immune memory targets an otherwise usually harmless substance. IgE-mediated reactions are important but not the only allergy mechanism, and asthma includes multiple inflammatory and nonallergic phenotypes.
Pollen, food, venom, medicines, mites, animals, molds, occupational material, and other antigens enter distinct barrier tissues.
Epithelial cytokines and dendritic-cell activation can favor helper T-cell programs associated with allergy and barrier repair.
Type-2-associated cytokines and cell contact support class switching toward IgE in susceptible contexts.
Plasma cells secrete IgE that binds high-affinity FcεRI receptors on mast cells and basophils.
Specific IgE or a positive test indicates sensitization but does not alone prove clinically important allergy.
Multivalent allergen binds adjacent mast-cell IgE molecules, initiating rapid signaling and granule release.
Histamine can cause itch, hives, sneezing, vascular leak, nasal symptoms, gut effects, and selected smooth-muscle responses.
Newly synthesized mediators contribute to bronchoconstriction, mucus, edema, and recruitment beyond the immediate granule phase.
Cytokines and chemokines recruit eosinophils and other cells that can sustain epithelial injury and reactivity for hours or days.
Airway swelling, bronchospasm, vasodilation, vascular leak, low pressure, and gastrointestinal symptoms can create a life-threatening emergency.
Inflamed or sensitized airways contract excessively to allergens, infection, exercise, cold air, irritants, or other triggers.
Airway muscle contraction rapidly narrows caliber, especially affecting expiratory flow and producing uneven ventilation.
Secretions, epithelial shedding, and wall swelling add obstruction while cough and clearance mechanisms change.
Smooth-muscle mass, basement-membrane-associated matrix, glands, vessels, and epithelial behavior can change over time.
H1 antihistamines reduce selected histamine symptoms but do not treat all asthma biology or substitute for emergency anaphylaxis care.
Inhaled corticosteroids, bronchodilators, leukotriene modifiers, and targeted biologics act at different stages and require an individualized plan.